ENDP Endo International plc Stock Quote

ENDP [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | Ireland

Index	-	P/E	-	EPS (ttm)	-2.92	Insider Own	0.50%	Shs Outstand	233.88M	Perf Week	-48.87%
Market Cap	127.94M	Forward P/E	1.02	EPS next Y	0.57	Insider Trans	0.00%	Shs Float	232.95M	Perf Month	-77.69%
Income	-681.40M	PEG	-	EPS next Q	0.44	Inst Own	82.30%	Short Float	15.07%	Perf Quarter	-81.36%
Sales	2.93B	P/S	0.04	EPS this Y	-584.60%	Inst Trans	1.84%	Short Ratio	5.28	Perf Half Y	-91.41%
Book/sh	-5.61	P/B	-	EPS next Y	-37.53%	ROA	-8.20%	Target Price	1.33	Perf Year	-89.88%
Cash/sh	6.38	P/C	0.09	EPS next 5Y	-	ROE	75.30%	52W Range	0.36 - 7.07	Perf YTD	-84.63%
Dividend	-	P/FCF	0.45	EPS past 5Y	29.90%	ROI	-0.30%	52W High	-91.82%	Beta	1.23
Dividend %	-	Quick Ratio	1.60	Sales past 5Y	-5.70%	Gross Margin	71.80%	52W Low	59.83%	ATR	0.23
Employees	3103	Current Ratio	1.80	Sales Q/Q	-9.10%	Oper. Margin	-3.80%	RSI (14)	19.07	Volatility	52.06% 21.35%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-241.60%	Profit Margin	-24.80%	Rel Volume	4.96	Prev Close	0.58
Shortable	Yes	LT Debt/Eq	-	Earnings	May 05 AMC	Payout	-	Avg Volume	6.64M	Price	0.58
Recom	3.00	SMA20	-63.91%	SMA50	-72.33%	SMA200	-83.01%	Volume	0	Change	0.00%

May-06-22

Downgrade

Piper Sandler

Neutral → Underweight

$3 → $1

Mar-02-22

Downgrade

Barclays

Equal Weight → Underweight

$5 → $2

Aug-31-21

Downgrade

Piper Sandler

Overweight → Neutral

$10 → $3

Apr-07-21

Resumed

RBC Capital Mkts

Sector Perform

Jul-27-20

Initiated

Goldman

Sell

Apr-24-20

Initiated

Citigroup

Buy

Jan-03-20

Upgrade

Piper Jaffray

Neutral → Overweight

$5 → $7

Jul-15-19

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jun-17-19

Downgrade

Citigroup

Buy → Neutral

Jun-11-19

Initiated

Barclays

Equal Weight

May-13-19

Downgrade

JP Morgan

Neutral → Underweight

Mar-20-19

Initiated

SunTrust

Buy

Mar-05-19

Downgrade

SVB Leerink

Outperform → Mkt Perform

Nov-09-18

Upgrade

Canaccord Genuity

Hold → Buy

$16 → $20

Sep-11-18

Upgrade

Goldman

Sell → Neutral

Aug-13-18

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

Aug-09-18

Reiterated

Stifel

Hold

$10 → $17

Jun-27-18

Upgrade

Citigroup

Neutral → Buy

Apr-04-18

Downgrade

Mizuho

Buy → Neutral

$12 → $7

Feb-28-18

Downgrade

Gabelli & Co

Buy → Hold

May-19-22 12:15PM	Endo (ENDP) Crashes 46.54% as it Looks to Restructure Debt Zacks -6.82%
May-18-22 04:45PM	Why Shares of Endo International Plummeted 69% on Wednesday Motley Fool -46.54%
03:25PM	What Is Happening With Endo Shares Today Benzinga
May-16-22 09:05AM	Is it Still Worth Keeping Your Endo International (ENDP) Shares? Insider Monkey
May-06-22 01:23PM	Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results Zacks -29.70%
12:16PM	Why Endo International Stock Is Cratering Today Motley Fool
May-05-22 07:15PM	Endo International (ENDP) Surpasses Q1 Earnings and Revenue Estimates Zacks -9.01%
04:30PM	ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS PR Newswire
04:30PM	ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS CNW Group
04:15PM	Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting PR Newswire
May-04-22 03:19PM	Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More Zacks
May-03-22 12:10PM	Can Endo (ENDP) Keep the Earnings Surprise Streak Alive? Zacks
May-02-22 01:11PM	Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M Benzinga +8.50%
07:55AM	Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar CNW Group
07:30AM	Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candidates to Endo Ventures Limited GlobeNewswire
Apr-28-22 06:00PM	Endo International (ENDP) Stock Sinks As Market Gains: What You Should Know Zacks
03:02PM	Analysts Estimate Endo International (ENDP) to Report a Decline in Earnings: What to Look Out for Zacks
07:30AM	Nevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in a Prefilled Syringe GlobeNewswire
Apr-25-22 09:00AM	Walgreens, Teva face San Francisco trial over opioid epidemic Reuters
Apr-20-22 05:23PM	Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo PR Newswire -5.47%
05:23PM	Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo CNW Group
Apr-19-22 02:21PM	UPDATE 4-Alabama settles opioid claims with J&J, McKesson, Endo for $276 mln -attorney general Reuters +8.30%
Apr-12-22 06:15PM	Endo International (ENDP) Dips More Than Broader Markets: What You Should Know Zacks
05:00PM	Endo to Announce First-Quarter 2022 Financial Results PR Newswire
05:00PM	Endo to Announce First-Quarter 2022 Financial Results CNW Group
Apr-04-22 06:00AM	West Virginia faces off against J&J, drugmakers at trial over opioid epidemic Reuters
Apr-01-22 06:00PM	Endo International (ENDP) Flat As Market Gains: What You Should Know Zacks
Mar-30-22 12:43PM	Teva, Others to Pay Millions in Florida Opioid Settlements Barrons.com
11:30AM	Why Is Endo (ENDP) Up 4.6% Since Last Earnings Report? Zacks
Mar-28-22 07:30AM	Nevakar Injectables Announces the Launch of Ready-to-Use Ephedrine Injection Vials GlobeNewswire
07:30AM	Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials PR Newswire
Mar-24-22 04:58PM	Texas demands drug companies turn over documents on 'puberty blocking' drugs for children Reuters
Mar-23-22 06:00PM	Endo International (ENDP) Dips More Than Broader Markets: What You Should Know Zacks
Mar-15-22 06:00PM	Endo International (ENDP) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-08-22 12:06PM	Qwo gets 'Butt First' blitz as Endo looks to generate buzz for its injectable cellulite treatment American City Business Journals
Mar-03-22 04:30PM	Endo Launches New Living Our Values Program to Recognize Outstanding Team Members CNW Group
Mar-02-22 09:15AM	Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events PR Newswire -5.81%
Mar-01-22 04:45PM	Why Shares of Endo International Slumped 22.8% on Tuesday Motley Fool -22.51%
11:19AM	Endo (ENDP) Surpasses Q4 Earnings and Revenue Estimates Zacks
Feb-28-22 04:15PM	ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS CNW Group
Feb-23-22 10:11AM	Endo (ENDP) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-21-22 03:01PM	Analysts Estimate Endo International (ENDP) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-18-22 06:00PM	Endo International (ENDP) Stock Moves -0.65%: What You Should Know Zacks
Feb-14-22 09:59AM	Is Endo International (ENDP) A Great Long-Term Investment? Insider Monkey
Feb-11-22 07:30AM	Endo Comments on Default Judgment on Liability in Tennessee State Court CNW Group
Feb-08-22 12:10PM	Can Endo (ENDP) Keep the Earnings Surprise Streak Alive? Zacks
Feb-07-22 06:00PM	Endo International (ENDP) Gains As Market Dips: What You Should Know Zacks
07:30AM	Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles PR Newswire
Feb-01-22 06:00PM	Endo International (ENDP) Gains But Lags Market: What You Should Know Zacks
09:30AM	Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
Jan-25-22 05:00PM	Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results PR Newswire
05:00PM	Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results CNW Group
Jan-24-22 06:00PM	Endo International (ENDP) Outpaces Stock Market Gains: What You Should Know Zacks
Jan-20-22 06:15PM	Endo International (ENDP) Stock Moves -0.9%: What You Should Know Zacks
Jan-18-22 10:12AM	Endo reaches $65M settlement deal to resolve opioid litigation in Florida American City Business Journals
07:52AM	Drugmaker Endo signs $65 million opioid settlement with Florida Reuters
07:48AM	Drugmaker Endo signs $65 mln opioid settlement with Florida Reuters
07:00AM	Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims PR Newswire
07:00AM	Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims CNW Group
Jan-17-22 07:30AM	Paladin Labs Announces the Launch of Xydalba® (dalbavancin for injection) in Canada CNW Group
Jan-14-22 06:00PM	Endo International (ENDP) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-13-22 07:30AM	Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism PR Newswire -6.20%
07:30AM	Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism CNW Group
Jan-12-22 12:20PM	Endo International plc (ENDP): Are Hedge Funds Right About This Stock? Insider Monkey
Jan-11-22 07:00AM	Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development PR Newswire
07:00AM	Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development CNW Group
Jan-10-22 07:30AM	Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education Unfold PR Newswire +5.03%
Jan-06-22 06:00PM	Endo International (ENDP) Dips More Than Broader Markets: What You Should Know Zacks
Jan-04-22 06:25PM	Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution CNW Group
05:00PM	Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference PR Newswire
05:00PM	Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference CNW Group
Dec-30-21 10:58AM	Can-Fite (CANF) Files Patent Applications for Namodenoson Zacks
10:07AM	AstraZeneca (AZN) Closes Agreement for Eplontersen With Ionis Zacks
Dec-28-21 12:04PM	Pluristem (PSTI) Misses Study Goal to Treat COVID-Related ARDS Zacks
Dec-27-21 07:19AM	ChemoCentryx's (CCXI) Stock Increases on Tavneos' FDA Nod Zacks
Dec-23-21 02:19PM	Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims PR Newswire
02:19PM	Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims CNW Group
02:11PM	UPDATE 2-Drugmaker Endo strikes $63 million opioid settlement with Texas Reuters
01:44PM	Drugmaker Endo strikes $63 million opioid settlement with Texas Reuters
01:25PM	Drugmaker Endo strikes $63 million opioid settlement with Texas Reuters
11:22AM	Novartis (NVS) Gets FDA Nod for Cosentyx's Label Expansion Zacks
06:00AM	Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI® (Cenobamate) in Canada CNW Group
Dec-22-21 10:44AM	AstraZeneca's (AZN) Ultomiris sBLA Gets FDA Priority Review Zacks
Dec-16-21 10:26AM	Jazz (JAZZ) Enrols First Patient in Essential Tremor Study Zacks -14.12%
09:53AM	7 of the Best Small-Cap Stocks to Buy Before 2022 InvestorPlace
Dec-15-21 02:54PM	UPDATE 1-U.S. FDA approves Eagles generic version of Endo blood pressure drug Reuters
10:44AM	AbbVie (ABBV) Rinvoq Gets FDA Nod for Active Psoriatic Arthritis Zacks
10:23AM	Endo Announces Favorable Final Ruling in California State Court Opioid Trial CNW Group
Dec-14-21 05:17PM	Intellia (NTLA) Begins Dosing in Hereditary Angioedema Study Zacks -5.32%
Dec-08-21 11:28AM	Recursion (RXRX) Inks Neuroscience and Oncology Deal With Roche Zacks
Dec-07-21 05:43PM	Sanofi's (SNY) Filing for Rare Disease Drug Accepted by EMA Zacks
10:14AM	Merck (MRK) Pauses Enrolment in HIV-1 Prevention Studies Zacks
Dec-06-21 11:51AM	Amicus (FOLD) Filings for AT-GAA in Pompe Disease Accepted by EMA Zacks
11:45AM	Merck's (MRK) Keytruda Gets FDA Nod for Expanded Melanoma Use Zacks
Dec-03-21 03:30PM	Dyne Therapeutics (DYN) Submits IND to FDA for DMD Candidate Zacks -5.49%
Dec-02-21 05:37PM	Sage (SAGE), Biogen (BIIB) Report Data on Depression Drug Zacks
09:21AM	Best Momentum Stocks to Buy for December 2nd Zacks
Dec-01-21 01:52PM	AbbVie (ABBV) Files for Skyrizi to Treat Crohn's Disease in EU Zacks -5.89%
01:38PM	Jazz (JAZZ) Begins Zepzelca Combo Study for First-Line SCLC Zacks
10:06AM	ImmunoGen (IMGN) Surges on Successful Ovarian Cancer Study Zacks

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Barry Patrick A	EVP & Pres,Global Comm Ops	Mar 30	Option Exercise	0.00	16,957	0	174,686	Mar 31 04:09 PM
Maletta Matthew Joseph	EVP, CLO & Company Secretary	Mar 30	Option Exercise	0.00	34,414	0	361,264	Mar 31 04:06 PM
Bradley Mark T.	EVP, Chief Financial Officer	Mar 30	Option Exercise	0.00	10,735	0	104,534	Mar 31 04:03 PM
Coleman Blaise	President, CEO	Mar 30	Option Exercise	0.00	35,910	0	432,203	Mar 31 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience